These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19156896)

  • 1. Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting STent (TEST) registry.
    Tamburino C; Di Salvo ME; Capodanno D; Capranzano P; Parisi R; Mirabella F; Scardaci F; Ussia G; Galassi AR; Fiscella D; Mehran R; Dangas G
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):243-8. PubMed ID: 19156896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical appraisal of the Janus carbostent.
    Kornowski R
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):249-50. PubMed ID: 19156897
    [No Abstract]   [Full Text] [Related]  

  • 3. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility, safety, and efficacy of a novel polymeric pimecrolimus-eluting stent: traditional pre-clinical safety end points failed to predict 6-month clinical angiographic results.
    Ormiston JA; Webster MW; Schwartz RS; Gladding P; Stewart JT; Kay IP; Ruygrok PN; Hatrick R
    JACC Cardiovasc Interv; 2009 Oct; 2(10):1017-24. PubMed ID: 19850264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: 12-month data from the E-Five registry.
    Lotan C; Meredith IT; Mauri L; Liu M; Rothman MT;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1227-35. PubMed ID: 20129549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial.
    Meredith IT; Worthley S; Whitbourn R; Walters DL; McClean D; Horrigan M; Popma JJ; Cutlip DE; DePaoli A; Negoita M; Fitzgerald PJ;
    JACC Cardiovasc Interv; 2009 Oct; 2(10):977-85. PubMed ID: 19850258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment.
    Stella PR; Belkacemi A; Waksman R; Stahnke S; Torguson R; von Strandmann RP; Agostoni P; Sangiorgi G; Silber S;
    EuroIntervention; 2011 Oct; 7(6):705-10. PubMed ID: 21959672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trial.
    Rodriguez AE; Vigo CF; Delacasa A; Mieres J; Fernandez-Pereira C; Bernardi V; Bettinoti M; Rodriguez-Granillo AM; Rodriguez-Granillo G; Santaera O; Curotto V; Rubilar B; Tronge J; Palacios IF; Antoniucci D;
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):335-42. PubMed ID: 20824769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
    Novack V; Cutlip D; Kleiman N; Pencina M; Mauri L; Yen CH; Berger P; Goldberg S; Kellett M; Waksman R; Hong M; Raizner AE; Cohen DJ
    JACC Cardiovasc Interv; 2009 Aug; 2(8):767-75. PubMed ID: 19695546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
    Chevalier B; Silber S; Park SJ; Garcia E; Schuler G; Suryapranata H; Koolen J; Hauptmann KE; Wijns W; Morice MC; Carrie D; van Es GA; Nagai H; Detiege D; Paunovic D; Serruys PW;
    Circ Cardiovasc Interv; 2009 Jun; 2(3):188-95. PubMed ID: 20031715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
    Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents.
    Stefanini GG; Kalesan B; Pilgrim T; Räber L; Onuma Y; Silber S; Serruys PW; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2012 Mar; 5(3):301-10. PubMed ID: 22440496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions.
    Uchida T; Popma J; Stone GW; Ellis SG; Turco MA; Ormiston JA; Muramatsu T; Nakamura M; Nanto S; Yokoi H; Baim DS
    JACC Cardiovasc Interv; 2010 Apr; 3(4):403-11. PubMed ID: 20398868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre RegIstry for stenting of uNprotecteD LMCA stenosis) registry.
    Carrié D; Eltchaninoff H; Lefèvre T; Silvestri M; Brunel P; Fajadet J; Moynagh A; Gilard M; Koning R; Dibie A; Darremont O; Lablanche JM; Blanchard D;
    EuroIntervention; 2011 Oct; 7(6):680-8. PubMed ID: 21986326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug eluting stenting in bifurcation coronary lesions long-term results applying a systematic treatment strategy.
    Assali AR; Vaknin-Assa H; Lev E; Teplitsky I; Dvir D; Brosh D; Bental T; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):615-22. PubMed ID: 22162218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
    Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
    J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation.
    Vlaar PJ; Zijlstra F
    JACC Cardiovasc Interv; 2009 Aug; 2(8):776-8. PubMed ID: 19695547
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial.
    Kufner S; Cassese S; Valeskini M; Neumann FJ; Schulz-Schüpke S; Hoppmann P; Fusaro M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2015 Jun; 8(7):877-84. PubMed ID: 26003022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and angiographic outcomes with an everolimus-eluting stent in large coronary arteries: the SPIRIT III 4.0 mm registry.
    Gordon PC; Applegate RJ; Hermiller JB; Weinsier SB; Doostzadeh J; Cao S; Sudhir K; Lansky AJ; Stone GW
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):179-86. PubMed ID: 19877267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON).
    Rozenman Y; Witzling V; Tamari I; Turkisher V; Kriviski M; Bode C; Henry P; Teiger E; Cebrian A; Stoll HP; Spaulding C
    EuroIntervention; 2009 Jun; 5(2):219-23. PubMed ID: 19527979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.